Abnormal expression of MDM-2 in breast carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abnormal expression of MDM-2 in breast carcinomas

Published:1996-06 Issue:2 Volume:37 Page:179-188
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Bueso-Ramos Carlos E.,Manshouri Taghi,Haidar Mohammad A.,Yang Yun,McCown Patrick,Ordonez Nelson,Glassman Armand,Sneige Nour,Albitar Maher

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF01806499.pdf

Reference33 articles.

1. Fakharzadeh SS, Trusko SP, George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10: 1565–1569, 1991

2. Momand J, Zambetti GP, Olson DC, George DL, Levine AJ: The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237–1245, 1992

3. Barak Y, Juven T, Haffner R, Oren M: MDM2 expression is induced by wild type p53 activity. EMBO J 2: 461–468, 1993

4. Chen J, Marechal V, Levine AJ: Mapping of the p53 and MDM2 interaction domains. Mol Cell Biol 13: 4107–4114, 1993

5. Wu X, Bayle JH, Olson D, Levine AJ: The p53-MDM-2 autoregulatory feedback loop. Genes Dev 7: 1126–1132, 1993

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of MDM2 Overexpression in Ameloblastomas with MDM2 Amplification and BRAFV600E Expression;International Journal of Molecular Sciences;2024-02-13

2. Exploring CDKs, Ras-ERK, and PI3K-Aktin Abnormal Signaling and Cancer;Journal of Cancer Research Updates;2022-10-27

3. Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer;Signal Transduction and Targeted Therapy;2022-02-04

4. Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography;Anti-Cancer Agents in Medicinal Chemistry;2022-02

5. Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an 18F-Labeled Analogue of the MDM2 Inhibitor SP-141;Pharmaceuticals;2021-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3